Jayne Gershkowitz Email & Phone Number

Princeton, New Jersey, United States

C-suite executive with a systemic strategy to global internal and external Patient Advocacy that defines corporate culture, informs all aspects of development and access to orphan drug products, and creates educational and supportive initiatives to improve the lives of individuals and families living with rare diseases. Industry leader in the advancement of Patient Advocacy as an essential function in corporate life sciences, of Public Policy as an advocacy-based approach to identifying and solving access challenges, and of helping affected individuals and families become their own best advocates.

Cranbury, Nj

- Responsible for relationship development and implementation strategy for global interactions with key opinion leaders in patient, HCP and health policy arenas. Direct an integrated team of patient advocates and medical science liaisons.- Lead a partnership approach to orphan drug development process, particularly with clinical programs, trial design, enrollment and retention through direction on variety of cross-functional teams and Executive Team participation.- Involved with industry, advocacy and policy initiatives to advance access to investigational and approved products for people living with rare diseases with proactive, flexible perspectives.- Maintain leadership role to ensure elevation and acceptance of Patient Advocacy as a strategic function in the life sciences industry.

- Develop and implement education, outreach, communications and support strategies to increase awareness and understanding of pharmacological chaperone technology, company clinical programs while building and enhancing ongoing relationships with patient community organizations, professional associations and leaders in the rare disease space - Lead Patient Advocacy staff in disease program support and information to individual patients and families affected by lysosomal storage diseases- Represent patient perspective in all cross-functional teams and assist in clinical trial protocols- Manage company charitable contributions program- Collaborate with key state and national biotech and policy organizations on public policy/legislative initiatives- Increase industry discussion of key public policy, bioethics and patient advocacy issues by chairing and presenting sessions at major conference/symposia sessions

Ba, Double Major: Newspaper Journalism And English Literature

Activities and Societies: Women In Communications, Daily Orange

Marketing/Marketing Management, General